DanDrit Overview

  • Founded
  • 2001
  • Status
  • Acquired/​Merged
  • Latest Deal Type
  • M&A
  • Financing Rounds
  • 3

DanDrit General Information


Enochian BioSciences Inc is a biopharmaceutical company. It is engaged in identifying, developing, manufacturing and commercializing gene therapies. It develops cures and providing prevention for infectious diseases and cancer. It is also engaged in developing HIV preventative vaccine and cures and Cellular immune-oncology products.

Contact Information

Formerly Known As
DanDrit Biotech USA
Ownership Status
Financing Status
Corporate Backed or Acquired
Primary Industry
Drug Discovery
Other Industries
Enochian BioSciences
Primary Office
  • 375 Park Avenue
  • Suite 2607
  • New York, NY 10152
  • United States
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

DanDrit Valuation & Funding

Deal Type Date Amount Valuation/
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore DanDrit‘s full profile, request access.

Request a free trial

DanDrit Comparisons

HQ Location
Total Raised
Post Valuation
Last Financing Details
Enochian BioSciences Inc is a biopharmaceutical company. It is engaged in identifying, developing, manufacturing and com
Drug Discovery
New York, NY
000000&0 000.00


it in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat
0000 000000000
Bethesda, MD
00 As of 0000
000000000 - 00000


eniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute
0000 000000000
Baton Rouge, LA
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

DanDrit Competitors (12)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Northwest Biotherapeutics Corporation Bethesda, MD 00 00000 000000000 - 00000
0000000000 Corporate Backed or Acquired Baton Rouge, LA 000000000000
0000000 Formerly VC-backed Cambridge, MA 00 00000 00000000 00000
0000000 0000000000 Formerly VC-backed Watertown, MA 00 00000 000000000 00000
00000 Private Equity-Backed Prague, Czech Republic 000 000000000000
You’re viewing 5 of 12 competitors. Get the full list »

DanDrit Executive Team (2)

Name Title Board Seat Contact Info
Luisa Puche Chief Financial Officer & Principal Accounting Officer
To view DanDrit’s complete executive team members history, request access »